Daniel Huang, MegaRobo founder and CEO (Bosch Presse)

Gold­man Sachs leads a $300M round in­to a Chi­na biotech uni­corn boast­ing of its AI/ro­bot­ics prowess

The pub­lic mar­kets may have turned in­to a killing zone for biotechs and a harsh en­vi­ron­ment for tech stocks gen­er­al­ly, but that doesn’t mean the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.